TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Argos Therapeutics Inc (NASDAQ:ARGS) Investor Securities Class Action Lawsuit 03/15/2017

  • If you purchased shares of Argos Therapeutics Inc (NASDAQ:ARGS), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

September 26, 2017 - The case was voluntarily dismissed. March 15, 2017 (Shareholders Foundation) - An investor in shares of Argos Therapeutics Inc (NASDAQ:ARGS) filed a lawsuit in the U.S. District Court for the Middle District of North Carolina over alleged violations of Federal Securities Laws by Argos Therapeutics Inc in connection with certain allegedly false and misleading stat...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: